期刊文献+

高效液相色谱法测定人血浆中比阿培南的浓度 被引量:1

Determination of biapenem in human plasma by HPLC
下载PDF
导出
摘要 目的建立人血浆中比阿培南的高效液相检测方法。方法色谱柱为Waters ACQUITY○RBEH C18柱(250×4.6mm,5μm),流动相为乙腈∶水(15∶85,v/v);流速1.0 mL.min-1;检测波长为300nm,血浆样品处理选用亚胺培南为内标,采用乙腈沉淀蛋白。结果比阿培南在0.05-25.0μg.mL-1范围内线性良好(r=0.9988,加权系数为1/C2),HPLC测定定量限为0.05μg.mL-1,比阿培南浓度分别为0.1,5.0 and 20.0μg.mL-1血浆样本绝对回收率分别为94.28%,95.07%,93.96%,相对回收率分别为99.87%,102.55%,98.64%,精密度试验日内和日间RSD均小于15%,稳定性试验结果表明血浆样品在样品处理过程中较稳定(RSD<15%)。结论本方法灵敏度高,操作简便、快速,重复性好,适用于比阿培南血浆浓度测定。 OBJECTIVE To establish a HPLC method for the determination of biapenem in human plasma.METHODS The chromatography conditions were as follows: chromatographic column was Waters ACQUITY BEH C18 Column (250 × 4.6mm, 5μm), mobile phase was composed of acetonitile-water (15 : 85, v/v), the flow rate was 1.0 mL·min^-1 and the UV detection was carried out at 300 nm. The plasma samples were performed by protein precipitation with acetonitrile using imipenem as internal standard. RESULTS The assay was linear over the concentration range of 0. 05-25. 0μg·mL^-1 for biapenem in human plasma (r = 0. 9988, weighted by 1/C^2). The limit of quantitation for biapenem was 0.05μg·mL^-1. The absolute recoveries at concentrations 0.1,5.0 and 20.0μg·mL^-1 were 94.28 %, 95.07 %, 93.96 %, respectively, while the relative recoveries at concentrations 0.1,5.0 and 20.0μg·mL^-1 were 99.87 %, 102.55 %, 98.64 %, respectively. The method was accurate with all intra-and inter-day mean concentrations within 15 96 of nominal values at 0.1, 5.0 and 20.0μg·mL^-1. Furthermore, the stability results showed that biapenem was stable during sample processing (RSD 〈 15 % ) ). CONCLUSION This method was robust and suitable for determination of biapenem in human plasma.
作者 叶迎春
出处 《海峡药学》 2009年第9期154-156,共3页 Strait Pharmaceutical Journal
关键词 比阿培南 血药浓度 高效液相色谱法 Biapenem Plasma drug concentration HPLC
  • 相关文献

参考文献7

二级参考文献45

  • 1赵敏,赵国君,张勇.新碳青霉烯类抗生素比阿培南[J].中国临床药理学杂志,2005,21(5):390-392. 被引量:26
  • 2NAKASHIMA M, UEMATSU T, UENO K, et al. Phase Ⅰ study of L-627, biapenem, a new parenteral carbapenem antibiotic[J]. Int J Clin Pharmacol Ther Toxicol, 1993, 31(2): 70-76.
  • 3VESSILLIER S, DOCQUIER JD, RIVAL S, et al. Overproduction and biochemical characterization of the Chryseobacterium meningoseptieum BlaB metallo-beta-laetamase[J]. Antimierob Agents Chemother, 2002, 46(6): 1921-1927.
  • 4IKEDA K, IKAWA K, IKEDA A, et al. A simple and rapid determination of biapenem in plasma by high-performance liquid chromatography[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2006, 844(1): 148-152.
  • 5Hoban D J,Jones R N,Yamane N, et al. In viuo activity of three carbapenem antibiotics. Comparative studies with biapenem (L-627), imipenem, and mempenem against aerobic pathogens isolated worldwide [J]. Diagn Microbiol Infect Dis, 1993, 17(4):299.
  • 6Vessillier S, Docquier J D. Overproduction and biochemical characterization of the chryseobacterium meningosepticum BlaB Metallo- β - Lactamase [ J ]. Antimicrob Agents Chemother, 2002,46 (6) : 1921.
  • 7Igari J, Watanabe M, Uehara N, et al. Changes in the antibacterial activity of chemotherapeutic agents (especially carbapenems ) for 10 species of clinical isolates between 1994 and 1996. Surveillance group of the sensitivities of clinical isolates to antibacterial agents [J]. Jpn J Antibiot ,2000,53(3) :157.
  • 8Suzuki Y, Nishinari C, Endo H, et al. Antimicrobial activities of carbapenems and forth generation cephems against chnically isolated strains [J]. Jpn J Antibiot, 2001,54(9) :473.
  • 9Watanabe A, Tokue Y, Takahashi H, et al . In vitro activity of biapenem(BIPM) against clinically isolated respiratory pathogens in 1996 - 1998 [J]. Jpn J Antibiot, 1999,52(12) :690.
  • 10Murase M. In vitro antibacterial activities of carbapenems against clinical isolates [J]. Jpn J Antibiot, 1999,52( 11 ) :667.

共引文献56

同被引文献11

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部